Curcumin
- Generic Name
- Curcumin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20O6
- CAS Number
- 458-37-7
- Unique Ingredient Identifier
- IT942ZTH98
- Background
Curcumin, also known as diferuloylmethane, is an active component in the golden spice turmeric (Curcuma longa) and in Curcuma xanthorrhiza oil. It is a highly pleiotropic molecule that exhibits antibacterial, anti-inflammatory, hypoglycemic, antioxidant, wound-healing, and antimicrobial activities . Due to these properties, curcumin has been investigated for...
- Indication
No approved therapeutic indications.
- Associated Conditions
- -
- Associated Therapies
- -
Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients
- Conditions
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-11-01
- Lead Sponsor
- Mashhad University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT01344291
- Locations
- 🇮🇷
Mashad University of Medical Sciences, Mashad, Khorasan Razavi, Iran, Islamic Republic of
Curcumin Pharmacokinetics
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 12
- Registration Number
- NCT01330810
- Locations
- 🇺🇸
UNC Department of Family Medicine, Chapel Hill, North Carolina, United States
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT01269203
Oral Curcumin for Radiation Dermatitis
- First Posted Date
- 2010-11-24
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 686
- Registration Number
- NCT01246973
Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair
- Conditions
- Interventions
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 606
- Registration Number
- NCT01225094
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦University of Calgary, Calgary, Alberta, Canada
🇨🇦Hamilton General Hospital, Hamilton, Ontario, Canada
Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
- Conditions
- Interventions
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Srinakharinwirot University
- Target Recruit Count
- 200
- Registration Number
- NCT01052025
- Locations
- 🇹ðŸ‡
HRH Princess Maha Chakri Sirindhorn Medical Center, Ongkarak, Nakornnayok, Thailand
Curcumin for Type 2 Diabetic Patients
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Srinakharinwirot University
- Target Recruit Count
- 200
- Registration Number
- NCT01052597
- Locations
- 🇹ðŸ‡
HRH Princess Maha Chakri Sirindhorn Medical Center, Ongkarak, Nakornnayok, Thailand
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
- Conditions
- Interventions
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT01048983
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2013-11-28
- Lead Sponsor
- Emory University
- Target Recruit Count
- 13
- Registration Number
- NCT01035580
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Curcumin in Pediatric Inflammatory Bowel Disease
- Conditions
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT00889161
- Locations
- 🇺🇸
Seattle Children's Hosptial, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.